Search Within

Gary Schwartz

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (25)
Groups
  1. Department of Medicine (64)
  2. Sarcoma Service (64)
  3. Solid Tumor Oncology Division (64)
  4. GSK Faculty (29)
  5. Biostatistics Service (24)
  6. Epidemiology and Biostatistics (24)

More Groups

People
  1. Mark Dickson (40)
  2. Richard Carvajal (26)
  3. William Tap (26)
  4. Mary Keohan (21)
  5. Sandra D'Angelo (20)
  6. Cristina Antonescu (16)

More People

Years
  1. 2023 (1)
  2. 2018 (1)
  3. 2015 (2)
  4. 2014 (7)
  5. 2013 (20)
  6. 2012 (13)

More Years

Publications
  1. Journal of Clinical Oncology (36)
  2. Clinical Cancer Research (4)
  3. Cancer Research (3)
  4. British Journal of Cancer (2)
  5. Sarcoma (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (36)
  2. American Association for Cancer Research (8)
  3. Wiley Blackwell (3)
  4. Hindawi Publishing Corporation (2)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902)
    Meeting Abstract

    Grilley-Olson, J. E.; Allred, J. B.; Schuetze, S.; Davis, E. J.; Wagner, M. J.; Poklepovic, A. S.; Waechter, B.; Riedel, R. F.; Welliver, M. X.; Berg, S. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • CDK4 inhibition and senescence: Pathway understanding leads to rational drug combinations
    Meeting Abstract

    Klein, M. E.; Kovatcheva, M.; Dickson, M. A.; Liu, D.; Crago, A. M.; Schwartz, G. K.; Tap, W. D.; Singer, S.; Koff, A.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome
    Journal Article

    Barlin, J. N.; Zhou, Q. C.; Leitao, M. M.; Bisogna, M.; Olvera, N.; Shih, K. K.; Jacobsen, A.; Schultz, N.; Tap, W. D.; Hensley, M. L.; more...
    NeoPlasia (2015)

    Fulltext@MSK | Save
  • MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition
    Journal Article

    Kovatcheva, M.; Liu, D. D.; Dickson, M. A.; Klein, M. E.; O'Connor, R.; Wilder, F. O.; Socci, N. D.; Tap, W. D.; Schwartz, G. K.; Singer, S.; more...
    Oncotarget (2015)

    Fulltext@MSK | Save
  • Combined KIT and CTLA-4 blockade in patients with refractory GIST and other advanced sarcomas
    Meeting Abstract

    Shoushtari, A. N.; D'Angelo, S. P.; Keohan, M. L.; Dickson, M. A.; Gounder, M. M.; Abdullah, A. K.; Erinjeri, J. P.; Bluth, M. J.; Ustoyev, Y.; Condy, M. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas
    Meeting Abstract

    Gounder, M. M.; Loong, H. H. F.; Nyquist-Schultz, K.; Baker, S.; Ustoyev, Y.; Tanner, L. R.; Shacham, S.; McCauley, D.; Rashal, T.; Saint-Martin, J. R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alliance A091102: Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma
    Meeting Abstract

    Dickson, M. A.; Mahoney, M. R.; Tap, W. D.; D'Angelo, S. P.; Keohan, M. L.; Van Tine, B. A.; Agulnik, M.; Horvath, L. E.; Schwartz, G. K.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alliance A091103: A multicenter phase II study of the angiopoietin-1 and-2 peptibody trebananib (AMG386) for the treatment of angiosarcoma (AS)
    Meeting Abstract

    D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Adkins, D.; Perdekamp, M. T. G.; Condy, M. M.; Hartley, E. W.; Antonescu, C. R.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • That's the "GIST" of it: Use of adjuvant imatinib after resection of a primary GI stromal tumor
    Journal Article

    Tap, W. D.; Schwartz, G. K.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: A randomized clinical trial
    Journal Article

    Carvajal, R. D.; Sosman, J. A.; Quevedo, J. F.; Milhem, M. M.; Joshua, A. M.; Kudchadkar, R. R.; Linette, G. P.; Gajewski, T. F.; Lutzky, J.; Lawson, D. H.; more...
    JAMA - Journal of the American Medical Association (2014)

    Fulltext@MSK | Save